As of June 10, 2025, Eargo Inc (EAR) reports a EV/EBITDA of -0.09.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing Eargo Inc's EV/EBITDA to Peers
To better understand Eargo Inc's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| Eargo Inc (EAR) | -0.09 |
| AxoGen Inc (AXGN) | 66.49 |
| Intuitive Surgical Inc (ISRG) | 61.15 |
| Dexcom Inc (DXCM) | 41.47 |
| Boston Scientific Corp (BSX) | 38.76 |
| IDEXX Laboratories Inc (IDXX) | 33.44 |
Compared to its competitors, Eargo Inc's EV/EBITDA is about average compared to peers, indicating market valuation in line with industry expectations.